Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-16

Clinical Trial Update: Benefits of Smart Pens in Type 1 Diabetes

View source ↗

Summary

A clinical trial investigating the benefits of smart pens for Type 1 diabetes is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Type 1 Diabetes | Status: NOT_YET_RECRUITING